Baird Medical Investment Holdings Ltd — Form SCHEDULE 13D
Filed July 31, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 28/100
What the filing says
ExcelFin SPAC LLC (San Francisco) filed a Schedule 13D on 31 July 2026 regarding acquisition of beneficial ownership in Baird Medical Investment Holdings Ltd (Hong Kong-based surgical instruments company, ~$69.7M in assets). The filing indicates a significant ownership stake acquisition, though specific share counts, percentages, and transaction dollar amounts are not disclosed in the header metadata provided.
Why this rating
Schedule 13D indicates material ownership stake by SPAC; however, without disclosed percentages, share counts, or transaction value, cannot assess actual materiality. Routine disclosure filing at this early stage.
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.